Slowing Cognitive Decline with Lilly’s Alzheimer’s Drug
InnovationRx is an exclusive weekly healthcare news digest that provides you with the latest updates. Subscribe now to have it delivered straight to your inbox! Getty Recently, pharmaceutical giant Lilly shared its phase 3 trial results for donanemab, an innovative antibody treatment for Alzheimer’s, in the Journal of the American Medical Association. Donanemab works by …